The present invention relates to: a novel crystal form of cefditoren pivoxil readily convertible into an amorphous form, to be used as an active ingredient of a drug, and having high cefditoren pivoxil purity; and a preparation method therefor. The novel crystal form of cefditoren pivoxil shows an XRD pattern having peaks at 2&thetas; values of 8.500±0.2°, 10.535±0.2° and 16.400±0.2°.